Literature DB >> 17041249

The MDRD formula and validation.

P J Twomey, T M Reynolds.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17041249     DOI： 10.1093/qjmed/hcl108

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  5 in total

1.  A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

Authors:  Kyemyung Park; Yukyung Kim; Mijeong Son; Dongwoo Chae; Kyungsoo Park
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

2.  Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy.

Authors:  Laurence Viollet; Susan Gailey; David J Thornton; Neil R Friedman; Kevin M Flanigan; John D Mahan; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

3.  Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment.

Authors:  Agneta A Pagels; Birgitta Klang Söderkvist; Charlotte Medin; Britta Hylander; Susanne Heiwe
Journal:  Health Qual Life Outcomes       Date:  2012-06-18       Impact factor: 3.186

4.  Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.

Authors:  Marc G Vervloet; Arjan D van Zuilen; Annemieke C Heijboer; Piet M ter Wee; Michiel L Bots; Peter J Blankestijn; Jack F M Wetzels
Journal:  BMC Nephrol       Date:  2012-04-24       Impact factor: 2.388

5.  Estimating glomerular filtration rate in a population-based study.

Authors:  Anoop Shankar; Kristine E Lee; Barbara E K Klein; Paul Muntner; Peter C Brazy; Karen J Cruickshanks; F Javier Nieto; Lorraine G Danforth; Carla R Schubert; Michael Y Tsai; Ronald Klein
Journal:  Vasc Health Risk Manag       Date:  2010-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.